The effect of l-arginine supplementation on amelioration of oxygen support in severe COVID-19 pneumonia.
- 2022-12
- RCT · n = 74
- Clinical nutrition ESPEN 52
- Jananee Muralidharan
- Sindhu Kashyap
- Poorvikha S
- Mathew Jacob
- Anjali Ollapally
- Jyothi Idiculla
- John Michael Raj
- Tinku Thomas
- Anura V Kurpad
- PubMed: 36513483
- DOI: 10.1016/j.clnesp.2022.09.024
- High evidence
- Clinical
The median number of days to the cessation of O2 support estimated using Kaplan Meir survival analysis, was 3 days in the l-Arg group (95% confidence interval [CI]: 1.2, 4.7) and 5 days in the placebo group (95% CI, 4.1,5.8); P = 0.27.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 3 g daily